차이
문서의 선택한 두 판 사이의 차이를 보여줍니다.
양쪽 이전 판이전 판 | |||
med:cancer_pain [2014/03/18 14:04] – V_L | med:cancer_pain [2015/06/07 13:37] (현재) – 바깥 편집 127.0.0.1 | ||
---|---|---|---|
줄 1: | 줄 1: | ||
+ | ====== [Cancer Pain]====== | ||
+ | |||
+ | |||
+ | |||
+ | PAIN CONTROL IN ADVANCED CANCER | ||
+ | NCCN Guideline 2009 | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | =====PAIN===== | ||
+ | “an unpleasant sensory and emotional experience associated with actual or potential tissue damage” | ||
+ | |||
+ | |||
+ | * Always subjective | ||
+ | * What the patient says it is | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | =====PHYSICAL PAIN===== | ||
+ | |||
+ | * SOMATIC – Well localised, sharp, throbbing, and pressure-like pain (eg. bone metastases) | ||
+ | * VISCERAL – Often poorly localised, deep, aching, or colicky pain (eg. liver capsule pain) | ||
+ | * NEUROPATHIC- Burning, | ||
+ | |||
+ | ===== CANCER PAIN PREVALENCE===== | ||
+ | 64% of cancer patients suffer from pain, with 75% of those sufferers categorizing their pain as moderate to very severe((Meier DE. J Pain Symptom manage 2002)) | ||
+ | Moderate to severe pain in 50% of cancer patient ((Vainio A, J Pain Symptom manage 1996)) | ||
+ | More than 70% of patients with advanced cancer((Ventafridda V, Pain Rev 1996)) | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | =====MANAGEMENT OF CANCER PAIN===== | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | * Primary therapy – Surgery, | ||
+ | * Pharmacotherapy | ||
+ | * Indirect delivery system: systemic analgesia | ||
+ | * Direct delivery system: neuraxial drug delivery & neuroablation | ||
+ | * Other modalities – Physiatric, | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | =====THREE-STEP ANALGESIC LADDER, WHO 1986===== | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | STEP ONE | ||
+ | non-opioid +/- adjuvants | ||
+ | STEP TWO | ||
+ | weak opioid +/- non-opioid +/- adjuvants | ||
+ | STEP THREE | ||
+ | strong opioid + non-opioid +/- adjuvants | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | =====MANAGEMENT===== | ||
+ | ====PAIN ASSESSMENT==== | ||
+ | |||
+ | * Quantify pain intensity | ||
+ | * Ask patients to describe | ||
+ | * Comprehensive pain assessment– Quality, | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | =====PAIN ASSESSMENT===== | ||
+ | * Medical emergency | ||
+ | * Oncologic emergency | ||
+ | * Bone fracture | ||
+ | * brain metastasis | ||
+ | * infection | ||
+ | * Obstructed or perforated viscus | ||
+ | * Etc | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ====PRINCIPLES==== | ||
+ | * Opioid begin bowel regimen | ||
+ | * Recognize and treat analgesic side effects | ||
+ | * Consider adding co-analgesics | ||
+ | * Provide psychosocial support | ||
+ | * Provide patient and family education | ||
+ | * Optimize non-pharmacologic interventions | ||
+ | * Prefer oral route | ||
+ | |||
+ | ====LEVELS OF PAIN INTENSITY==== | ||
+ | |||
+ | What number describes your worst pain in the past 24 hours? | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ====PAIN IN PATIENTS NOT TAKING OPIOIDS==== | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |Severe |Score 7-10| Rapid titration of short-acting opioid |Reevaluate within 24 hours| | ||
+ | |Moderate |Score 4-6| Titration of short-acting opioid|Reevaluate within 24-48 hours| | ||
+ | |Mild |Score 1-3| NSAID or acetaminophen, | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ===NSAIDS & ACETAMINOPHEN (1)=== | ||
+ | Use any well-worked NSAIDs in the past or | ||
+ | – Ibuprofen, | ||
+ | – Ketorolac 15-30mg IV q6hr for max. 5days, if needed | ||
+ | – Acetaminophen, | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | CAUTION: | ||
+ | – Renal, GI, cardiac toxicities, thrombocytopenia, | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | Monitoring | ||
+ | – BP, BUN, Cr, CBC, fecal occult blood | ||
+ | – Repeat every 3 month | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | Further decisions | ||
+ | – Two NSAIDs w/o efficacy use opioid | ||
+ | – Effective but toxicity another NSAID | ||
+ | – Consider tropical NSAIDs if not feasible | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ===OPIOID FOR ACUTE PAIN- Oral route=== | ||
+ | Initial oral dose | ||
+ | – 5-15mg of morphine sulfate or equivalent | ||
+ | – 10-20% of previous 24-hour dose | ||
+ | Reassessment of efficacy & side-effects every 60 min. | ||
+ | – Increased or unchanged: increase 50-100% | ||
+ | – Score 4-6: same dose reassess after 60 min | ||
+ | – Score 0-3: as per need, reassess after 2-3 hours | ||
+ | *Failure after 2-3 cycles: IV or reassessment | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ===OPIOID FOR ACUTE PAIN- IV route=== | ||
+ | Initial IV loading dose | ||
+ | |||
+ | - 2-5mg of IV morphine sulfate or equivalent | ||
+ | - 10-20% of previous 24-hour dose | ||
+ | |||
+ | |||
+ | Reassessment of efficacy & side-effects every 15 min. | ||
+ | - Increased or unchanged: increase 50-100% | ||
+ | - Score 4-6: same dose reassess after 15 min | ||
+ | - Score 0-3: as per need, reassess after 2-3 hours | ||
+ | |||
+ | |||
+ | * Failure after 2-3 cycles: alternate strategies or reassessment | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ===SUBSEQUANT TREATMENT FOR PAIN=== | ||
+ | Severe to moderate pain (score 4+) | ||
+ | – Reevaluate all | ||
+ | – Consider opioid rotation | ||
+ | – Consider specific pain syndrome | ||
+ | – Consider pain specialty consultation | ||
+ | – Consider interventional strategies | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | Mild pain (score 1-3) or goal | ||
+ | – Reevaluate pain at each contact | ||
+ | – Routine follow-up | ||
+ | |||